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In this thesis, a model-based closed-loop fluid resuscitation controller using 
mean arterial pressure (MAP) feedback is designed and later evaluated on an in-silico 
testbed. The controller is based on a subject specific model of blood volume and MAP 
response to fluid infusion. This simple hemodynamic model is described using five 
parameters only. The model was able to reproduce blood volume and blood pressure 
response to fluid infusion using an experimental dataset collected from 23 sheep and is 
therefore suitable to use for control design purposes. A model-reference adaptive 
control scheme was chosen to account for inter-subject variability captured in the 
parametric uncertainties of the underlying physiological model. Three versions of the 
control algorithm were studied under different measurement availability scenarios. In-
silico evaluation of the three controllers was done using a comprehensive 
cardiovascular physiology model on a cohort of 100 virtually generated patients. 
Results clearly show that a tradeoff exists between tracking and estimation performance 
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Chapter 1: Introduction 
1.1 Fluid Resuscitation 
Fluid resuscitation is the process of replenishing bodily fluids lost by vomiting, 
diarrhea, hemorrhage, burn injuries or during combat. If not treated rapidly, the patient 
experience hypovolemic shock [1]–[5]. Currently, clinicians perform fluid 
resuscitation through titration of fluids like crystalloids, colloids, normal saline and 
blood plasma while monitoring one or more physiologic endpoints (blood pressure, 
urinary output, cardiac output…etc.) [6]. This process is time consuming and is 
susceptible to human errors such as not providing optimal infusion dose or inadequate 
resuscitation. Delayed fluid resuscitation was shown to be a major cause of increased 
mortality and morbidity [7] while in other cases, excess administration of fluids results 
in edema and lack of oxygen delivery to tissues [8]. Moreover, inter-subject variability 
as well as how severely hypovolemic a patient is calls for continuous monitoring of 
patients’ hemodynamics while undergoing fluid resuscitation to effectively perform 
titration and admission of fluids with the least amount of fluid [9]. Therefore, it is 
desired to automate fluid resuscitation to help increase the quality of care and reduce 
the workload of clinicians.  
1.2 Autonomous Fluid Resuscitation and Current Physiological Mathematical Models 
 The goal of an autonomous fluid resuscitation system is similar to the current 
clinical resuscitation procedure: infusing fluid until a physiologic endpoint restores to 






not common. Most existing closed-loop resuscitation controllers are built on decision 
trees and gain tuning [10]–[13]. Realizing that there is much room for improving the 
efficacy and robustness of such systems, we ought to make use of credible 
mathematical models that can reproduce hemodynamic responses to fluid infusion for 
controller design. The design of a model-based controller for a physiological 
phenomenon is as complex as the underlying mathematical model. Therefore, a simple 
yet accurate model is sought to allow for relatively simple design procedures. 
Mathematical models that can reproduce hemodynamic responses to blood volume 
perturbations do exist. However, they suffer from one, or more, of the following 
disadvantages: (i) they are very complex involving hard nonlinearities and large 
number of parameters, which makes the design process of a model-based controller 
very difficult [14]–[19], or (ii) they are described using average values over a 
population, which no longer makes the model an individualized one that can capture 
intersubject variability [20], [21], and finally (iii) a class of these models are “black-
box” models that do not offer deep physiological interpretation [22]–[25]. 
Recently, a control-theoretic model of blood volume response to fluid infusion was 
shown to be able to reproduce results from experimental data [26]. This model captures 
the fluid shift between the intravascular and interstitial blood compartments, a primary 
mechanism in hemostasis. Described using four parameters only, this model is simple, 
accurate and can be used for model-based controller design very efficiently. Since 
absolute blood volume is not easily measured even in a lab setting, we propose an 
extension to the blood volume model to include mean arterial pressure response to fluid 






pressure and blood volume perturbations. This model was able to reproduce blood 
volume and blood pressure perturbations to fluid infusion in a set of experimental data 
collected from 23 sheep. Now, we have a simple, five-parameter model with 
physiological plausibility that enables the design of a closed-loop fluid resuscitation 
controller with mean arterial pressure as therapeutic endpoint using design approaches 
that are well established in the field of control theory [27]–[30]. Such controllers can 
be easier to implement clinically since blood pressure measurements are easily obtained 
and good approximation of mean arterial pressure (MAP) is calculated using [31] 
 𝑀𝐴𝑃 = 𝑃𝑑𝑖𝑎 +
1
3
 [𝑃𝑠𝑦𝑠 − 𝑃𝑑𝑖𝑎] (1) 
1.3 Controller Design Methodology and Evaluation 
 There are many sources of uncertainty when dealing with physiological 
systems, most importantly the inter-subject variability in both BV and MAP dynamics 
[32], [33]. Therefore, the choice of adaptive control theory was made to account for 
inter-subject variability that presents itself as uncertainty in the parameters of the 
underlying physiological model [27]. 
The extended model was used to design a closed-loop fluid resuscitation control 
algorithm that operates in two steps: (i) the hemodynamic model is individualized using 
the measurements collected from an initial fluid bolus infusion via system identification 
and (ii) a model reference adaptive controller (MRAC) is built using the model just 
individualized. This two-step control architecture was chosen to address persistent 






Three different versions of the proposed controller are investigated under different 
measurement availability scenarios. To assess the performance of the three versions, 
rigorous tests were done on an in-silico testbed using a well-known model of human 
cardiovascular physiology developed by Arthur Guyton [34]. The tests were done on a 
cohort of 100 subjects that were virtually generated by randomly perturbing key 
parameters in Guyton’s model within a plausible range. Results were statistically 
analyzed to examine the performance of the control algorithm in an in-silico scenario. 
1.4 Goals and Outline 
In this thesis, an adaptive model-based closed-loop fluid resuscitation control 
algorithm is designed and tested, in the goal of achieving an autonomous fluid 
resuscitation system. The underlying physiological model used for controller design is 
an extension to an existing blood volume response to fluid infusion and hemorrhage 
model. The model is first investigated from a physiological standpoint, then examined 
for its ability to reproduce hemodynamic responses using experimental data from 23 
sheep. Later, a two-step control architecture using blood pressure feedback was later 
designed and tested on an in-silico testbed using a well-established model of human 
cardiovascular physiology on a cohort of 100 virtually generated patients. Finally, the 
tracking and estimation performance of the controller was evaluated under different 
measurement availability scenarios. 
The thesis is organized as follows. In chapter 2, we cover the details of the 
physiological model used for control design and its validation with experimental data. 






stability properties. In chapter 4, we present the in-silico testing procedure of the 
proposed controllers. In chapter 5, we present the results of this study and investigate 
them from a statistical standpoint and finally conclude this work by summarizing the 






Chapter 2: Blood Volume-Blood Pressure Response to Fluid 
Infusion 
 In this chapter, we will present the structure of the physiological model that 
describes blood volume and mean arterial pressure response to fluid infusion and 
hemorrhage. We begin by giving a brief physiological background on the key 
mechanisms relating blood volume and mean arterial pressure changes to fluid 
infusion. Then, we describe the structure of the mathematical model in two parts: (i) 
blood volume response to fluid infusion and (ii) blood pressure response to blood 
volume perturbations. Finally, we examine the model’s validity by its ability to 
reproduce experimental data collected from 23 sheep. 
2.1 Physiological Background: Fluid Shift Mechanism 
 Perturbations in blood volume are caused by fluid infusion or hemorrhage (fluid 
loss). Bodily fluids are distributed between two main compartments: intracellular and 
extracellular [31], [35]. As the names suggest, intracellular fluid exists within the cell 
body while extracellular fluid exists outside the cells (figure 1). Extracellular fluid is 
further split into two compartments: interstitial fluid, which is the fluid between the 
cells in the tissue, and intravascular fluid which is the blood and plasma that flow in 
the arteries and veins. When fluid is gained or lost, fluid shifts between these 
compartments to maintain hemostasis. The shift mechanism and net fluid shift are 








Figure 1: Body fluids compartments 
Fluid shift occurs naturally depending on the body’s state. For example, during burn 
injury fluid shifts from intravascular to interstitial fluid to compensate for fluids lost in 
affected tissues. This causes intravascular fluid to decrease, lowering blood volume and 
blood pressure. Low blood volume can lead to hypovolemia which is treated with fluid 
infusion (fluid resuscitation) using isotonic fluids such as crystalloids or colloids [4]. 
Similarly, excessive fluid shift from intravascular to interstitial compartment can lead 
to hypervolemia or edema. This is treated using diuretics that decrease blood volume 
and cause fluid to shift back to intravascular compartment from interstitial one [36]. 
2.2 Modeling of Blood Volume Response to Fluid Infusion and Hemorrhage 
Given the complexity of the fluid shift mechanism, it is not easy to represent it 
mathematically in individual subjects. Current mathematical models that reproduce 
intravascular and interstitial volume changes in response to fluid infusion or loss are 
either black box models that lack physiological transparency and interpretability, or 
physiology-based first principle models that are complex and described by a large 






measure or estimate individually are used, which then makes the model not 
individualized but population-based [14]–[25].  
Recent work [26] presents a lumped-parameter model that is described using only four 
parameters, physiologically plausible and can be individualized for each subject. This 
model leverages the physiological principle that fluid shift between intravascular and 
interstitial compartments, can be regarded as the output of a hypothetical feedback 
controller (figure 2). The net fluid gain (or loss) act on the blood volume compartment 
to alter the blood volume which in turn alters the interstitial fluid volume. The complex 
physiological processes that cause the fluid shift are summarized by the two-way valve 
action. The valve action determines the amount of fluid flow between the two 
compartments 𝑞(𝑡) based the discrepancy between the target 𝑟𝐵(𝑡) versus actual blood 
volume change Δ𝑉𝐵(𝑡). The objective of the controller is to regulate the volume 
changes in intravascular and interstitial compartments at a target ratio of 1:𝛼 by 
retaining 1/(1 + 𝛼) fraction of the infused fluid in the intravascular compartment and 
shifting 𝛼/(1 + 𝛼) to the interstitial compartment. 
Infused fluids usually consist of electrolytes (crystalloids) such as Lactated Ringer’s 
solution or starch (colloids) such as Hextend, while lost fluids are usually plasma and 
red blood cells. Due to the difference in composition between infused and lost fluids, 
we denote the ratio between intravascular and interstitial volumetric changes in the 
steady state as 𝛼𝑢 in the case of fluid gain (infusion) and 𝛼𝑣 in the case of fluid loss 







Figure 2: Control-theoretic blood volume response to fluid infusion model 
 
Figure 3: Block diagram of blood volume response to fluid infusion model 














where 𝑢(𝑡) is the rate of fluid infusion and 𝑣(𝑡) is the rate of fluid loss due to 






of a simple P-controller as a function of the discrepancy between the desired and actual 
changes in BV: 
 𝑞(𝑡) = 𝑞(𝑒𝐵(𝑡)) = 𝐾(𝑟𝐵(𝑡) − Δ𝑉𝐵(𝑡)) (3) 
where 𝐾 is the feedback gain specifying the speed of fluid shift. Finally, by 
conservation of volume in the intravascular compartment we find that the rate of change 
in Δ𝑉𝐵(𝑡) is given by: 
 Δ?̇?𝐵(𝑡) = 𝑢(𝑡) − 𝑣(𝑡) − 𝑞(𝑡) (4) 
Combining equations (2)-(4) gives the complete differential equation describing blood 
volume changes in response to infusion and hemorrhage: 







2.3 Modeling of Blood Pressure Response to Blood Volume Perturbations 
Perturbations in blood volume (BV) caused by fluid shift entail perturbations in 
stroke volume and cardiac output. Stroke volume (SV) is the amount of blood pumped 
by the left ventricle per heartbeat while cardiac output (CO) is the amount of blood 
pumped by the left ventricle per minute [37]. These two can be related through: 
 𝐶𝑂(𝑡) = 𝑆𝑉(𝑡) ∗ 𝐻𝑅(𝑡) (6) 
Moreover, venous return (VR) is defined as the amount of blood that returns to the right 
atrium per minute, which should be equal to cardiac output at steady state [31]. The 
effects of BV on SV and MAP are described from two complementary standpoints: (i) 
Arthur Guyton and his proposed cardiac output-venous return theory that relates 






pressure MAP) through the total resistance of the veins and arteries (total peripheral 





From equation (7) we can express mean arterial pressure as: 
 𝑀𝐴𝑃(𝑡) = 𝐶𝑂(𝑡) ∗ 𝑇𝑃𝑅(𝑡) = 𝑆𝑉(𝑡) ∗ 𝐻𝑅(𝑡) ∗ 𝑇𝑃𝑅(𝑡) (8) 
Arterial elastance (𝐸𝑎) is defined as the product of heart rate and total peripheral 
resistance [31], [39]. Equation (8) then becomes: 
 𝑀𝐴𝑃(𝑡) = 𝐸𝑎(𝑡) ∗ 𝑆𝑉(𝑡) (9) 
(ii) The Frank-Starling mechanism with the left-ventricle pressure-volume loop theory 
dictates that changes in BV result in changes in SV and CO by altering the left ventricle 
end diastolic volume (LVEDV). This is described graphically in figure (4). 
 
Figure 4: Left-ventricular pressure-volume curve. Increased preload causes an increase in stroke volume, while 
increased afterload causes a decrease in stroke volume. 
Available data ([40], and figure(5)) suggests that a relationship exists between changes 
in stroke volume and changes in left ventricle volume, which in turn are affected by 
changes in blood volume. We propose to model this relationship between changes in 






 Δ𝑆𝑉(𝑡) = 𝐾𝑆𝑉(𝑡)Δ𝑉𝐵(𝑡) (10) 
where 𝐾𝑆𝑉 describes the sensitivity of SV to changes in BV. 
 
Figure 5: Sheep data shows a direct relationship between SV and BV 
Using equations (9-10), we can write: 
 
𝑀𝐴𝑃(𝑡) − 𝑀𝐴𝑃(0) = Δ𝑀𝐴𝑃(𝑡) = 𝐸𝑎(𝑡)𝑆𝑉(𝑡) − 𝐸𝑎(0)𝑆𝑉0 
Δ𝑀𝐴𝑃(𝑡) = (Δ𝑆𝑉(𝑡) + 𝑆𝑉0)𝐸𝑎(𝑡) − 𝑆𝑉0𝐸𝑎(0) 
Δ𝑀𝐴𝑃(𝑡) = Δ𝑆𝑉(𝑡)𝐸𝑎(𝑡) + 𝑆𝑉0𝐸𝑎(𝑡) − 𝑆𝑉0𝐸𝑎(0) 
Δ𝑀𝐴𝑃(𝑡) = 𝐾𝑆𝑉(𝑡)Δ𝑉𝐵(𝑡)𝐸𝑎(𝑡) + 𝑆𝑉0Δ𝐸𝑎(𝑡) 











where 𝐾𝐸𝑎  is the sensitivity of changes in arterial elastance 𝐸𝑎(𝑡) to changes in blood 
volume (see figure (6)). 
 
Figure 6: Sheep data shows opposite relationship between Ea and BV 
The relationship between MAP and BV is now simply expressed as: 
 Δ𝑀𝐴𝑃(𝑡) = 𝐾𝑚𝑎𝑝(𝑡)Δ𝑉𝐵(𝑡) (12) 
where 𝐾𝑚𝑎𝑝(𝑡) = 𝐾𝑆𝑉(𝑡)𝐸𝑎(𝑡) + 𝑆𝑉0𝐾𝐸𝑎(𝑡) is a time-varying gain that captures the 
relationship between changes in MAP and BV. Finally, the full mathematical model 
describing blood pressure response to fluid perturbations can be described using the 



















2.4 Validation with Experimental Data 
 In the previous two sections, we provided the structure of the mathematical 
model of blood volume and blood pressure response to fluid infusion and hemorrhage. 
In this section, we validate the efficacy of this simple model and its ability to reproduce 
a set of experimental data collected from 23 sheep animals. Although model validation 
was done using sheep data, great similarities exist between human and sheep 
cardiovascular system which allow for control design for fluid infusion to human 
subjects. This section shows that a simple model with four parameters that can 
reproduce experimental data, is a valid choice for model-based control design. 
2.4.1 Experimental Data 
 The experimental data were collected from 23 sheep undergoing controlled 
intravenous blood volume perturbations caused by hemorrhage and fluid infusion. 
Measurements included rates of infusion and hemorrhage, urinary output (UO), blood 
volume (BV), cardiac output (CO), blood pressure (mean arterial pressure MAP) and 
heart rate (HR). The protocol followed in conducting the experiment was approved by 
the Institutional Animal Care and Use Committee (IACUC) at the University of Texas 
Medical Branch [40]. The duration of study for each animal was 180 min. After 
recording baseline data, initial hemorrhage of 25 mL/kg was performed over 15 
minutes. Fluid infusion was initiated 30 min after the start of the hemorrhage and 
continued for 150 minutes. Second and third hemorrhage of 5 mL/kg were performed 
50 and 70 min after the start of the initial hemorrhage respectively, and each continued 






Baseline BV (𝑉𝐵0) was measured via indocyanine green dye (ICG) [43]. Moreover, 
Hematocrit (Hct), which is defined as the ratio between red blood cell volume and BV, 
was measured before and through the experiment at 5 to 10 min intervals. Hct 











where ℎ(𝑡) is the rate of fluid loss, 𝑉𝐵(𝑡) = Δ𝑉𝐵(𝑡) + 𝑉𝐵0 and 𝑉𝑅𝐵𝐶(0) = 𝐻𝑐𝑡(0)𝑉𝐵0. 
Other hemodynamic responses were measured at same time instants. 
2.4.2 System identification 
 A fully individualized system identification of the proposed hemodynamic 
model is performed. The model described by equation (13) is a time-varying linear 
model. Identification of time varying models is not a trivial task, in fact most literature 
that exists in this domain [44], [45] use a method of sliding time windows of certain 
width T and perform GLS (general least squares) then average the values over all time. 
Other methods include variations of Kalman filter where the time varying parameters 
are assumed to be driven by white noise [46]. We propose an alternative “two-layer” 







Figure 7: Two-level identification scheme for the hemodynamic linear time-varying model 
The two-layer optimization problem was set up using MATLAB© (Natick, MA) 
optimization toolbox. In each loop of MATLAB’s “fmincon” solver, a guess for BV 
model parameters (𝛼𝑣, 𝛼𝑢, 𝐾) is given to solve for Δ?̂?𝐵(𝑡). This drives a recursive least 
squares estimator that solves for ?̂?𝑚𝑎𝑝(𝑡) using 
 ?̇̂?𝑚𝑎𝑝(𝑡) = 𝛾Δ?̂?𝐵(𝑡|Θ){Δ𝑀𝐴𝑃(𝑡) − Δ𝑀𝐴?̂?(𝑡|Θ)} (15) 
From equation (15) we evaluate Δ𝑀𝐴?̂?(𝑡) as the product of ?̂?𝑚𝑎𝑝(𝑡) and Δ?̂?𝐵(𝑡). The 
optimization problem is solved for the optimal model parameters Θ∗ by minimizing the 
discrepancy between predicted and actual measurements: 
 Θ∗ = {𝛼𝑢
∗ , 𝛼𝑣
∗, 𝐾∗, 𝐾𝑚𝑎𝑝













Note that Δ𝑉𝐵(𝑡) = 𝑉𝐵(𝑡) − 𝑉𝐵0 and Δ𝑀𝐴𝑃(𝑡) = 𝑀𝐴𝑃(𝑡) − 𝑀𝐴𝑃0 are the true values 






true BV and MAP for all time respectively and finally, Δ?̂?𝐵(𝑡|Θ) and Δ𝑀𝐴?̂?(𝑡|Θ) are 
the model predicted values at each time 𝑡 and parameter estimates Θ. 
2.4.3 Results 
 Results of the proposed system identification procedure are shown in figure (8) 
and table (1). Figure (8) shows the true vs model-predicted BV, MAP and 𝐾𝑚𝑎𝑝(𝑡) for 
sheep (2,4,7,10,12,21). True values of 𝐾𝑚𝑎𝑝(𝑡) were obtained by dividing Δ𝑀𝐴𝑃/Δ𝑉𝐵. 
We can see that the model was able to reproduce the experimental data to high accuracy 
in sheep (2,4,10,21). However, for some sheep (like 7, 12), we can see that lack of 
excitation of the recursive LSE (i.e: Δ?̂?𝐵(𝑡) ≈ 0) caused inaccurate estimate for 
𝐾𝑚𝑎𝑝(𝑡) and hence Δ𝑀𝐴𝑃(𝑡). One way to correct this is to increase the adaptation gain 
𝛾 to higher values but risk fitting the noise in MAP data. Table (1) shows the results of 
model parameters (𝛼𝑢
∗ , 𝛼𝑣
∗ , 𝐾∗) for all 23 sheep as well as the RMSE for 𝐾𝑚𝑎𝑝(𝑡) 
estimation, MAP, and BV model predictions. When calculating RMSE for 𝐾𝑚𝑎𝑝(𝑡), 















Table 1: System identification results 








1 1.129371 0.736503 0.499937 6.425082 1 2.014615 0.064235 
2 2.189056 0.350914 0.490442 0.267033 1 1.650505 0.035538 
3 3.91598 2.999968 0.083817 1.6172 50 0.662869 0.060583 
4 1.284306 0.405203 0.499873 0.403862 1 2.541623 0.037102 
5 3.167091 0.78169 0.499951 0.830554 1 2.042132 0.033807 
6 2.087496 1.277491 0.093277 6.0877 10 2.99855 0.03753 
7 2.744221 2.798947 0.248002 16.3350 100 5.786654 0.038327 
8 4.815708 0.92952 0.076127 5.9939 5 2.184243 0.06438 
9 2.975871 0.949318 0.04115 1.302951 2 1.077198 0.091531 
10 1.000036 0.319161 0.499991 0.584892 1 0.941307 0.044453 
11 1.281386 1.192153 0.499917 3.400212 2 2.217937 0.032405 
12 3.394052 1.027561 0.221095 2.3485 10 2.296417 0.028135 
13 4.998773 1.075419 0.497458 3.6221 10 5.064654 0.036192 
14 4.999959 0.113891 0.382841 0.447262 1 0.866377 0.061169 
15 4.999802 0.755961 0.499986 0.413542 2 1.306922 0.033568 
16 4.99991 0.435235 0.499956 13.49035 2 2.159152 0.069577 
17 4.994477 1.067425 0.265812 0.416419 1 1.421104 0.041934 
18 1.000029 2.332503 0.10981 4.236475 5 1.045553 0.033631 
19 3.91019 2.36292 0.14011 1.454657 1000 1.84302 0.025485 
20 2.144853 2.381776 0.152031 12.84891 1 4.483123 0.04187 
21 4.314586 1.508877 0.343047 0.436498 1 2.373437 0.023738 
22 3.470183 1.144868 0.499761 0.59534 1 2.317259 0.020845 
23 1.745179 1.443239 0.447935 0.365676 1 1.863951 0.026929 
mean 3.111414 1.234371 0.330101 3.648875 
 
2.224287 0.042738 










Chapter 3: Development of Control Algorithm 
 In this chapter, we will highlight the control design steps and analyze its 
stability properties. We begin by explaining the motivation behind our choice of 
adaptive control methodology, followed by a set of assumptions to accommodate the 
application of adaptive control theory to the hemodynamic model described in chapter 
2. Finally, details of the two-step control architecture are given, and its stability 
properties are analyzed. 
3.1 Why adaptive control? 
As shown in table (1), model parameters for 23 sheep are uncertain and lie 
within some range. This inter-subject (subject-to-subject) variability presented by 
parametric uncertainty in physiological models [32] can be addressed with the use of 
adaptive control theory. In adaptive control, an estimate of the uncertain plant 
parameters (or controller parameters) is obtained online from input-output data [27], 
[30], [47], [48]. These estimates are used in the control input to achieve a desired 
tracking performance despite the presence of disturbances, parameter uncertainty or 
unknown variations in plant parameters. 
Although robust control design techniques also account for uncertainty, the choice of 
adaptive control over robust control lies in the learning behavior of adaptive control 
systems through online estimation, especially for systems with constant or slowly 
varying parameters. This gives superior performance since adaptive control systems 
improve performance as adaptation goes on, while robust controllers try to keep 






information in contrast to robust control which requires some knowledge of parameter 
bounds. The control design followed below is a modification of a semi-adaptive model 
reference adaptive control (MRAC) scheme, where the change in MAP follows a first 
order reference model trajectory. 
3.2 Assumptions 
 To accommodate the application of control theory to the model described by 
equation (13), several assumptions must be made. First, the time-varying parameter 
𝐾𝑚𝑎𝑝(𝑡) is assumed to be constant or slowly varying parameter (𝐾𝑚𝑎𝑝(𝑡) ≈ 𝐾𝑚𝑎𝑝). 
Second, in the resuscitation scenario described later in section (4.1), the hemorrhage 
(typically unknown) is assumed to have taken place and was stopped before the 
resuscitation process takes place. Therefore 𝛼𝑣 and 𝑣(𝑡) will be omitted from equation 
(13). Moreover, the relationship between MAP and BV due to infusion is passive [49], 
which suggests that the sign of 𝐾𝑚𝑎𝑝(𝑡) is usually positive. That is, for patients that 
respond to fluid infusion by increasing blood volume, the result is an increase in blood 
pressure. If we consider the 23 sheep data from section (2.4), figure (9) clearly show 
that (𝐾𝑚𝑎𝑝) is positive during the resuscitation phase for most subjects that responded 
to fluid infusion. Sheep #4,9 and 10 are example of such non-responsive subjects that 







Figure 9: Sign (𝐾𝑚𝑎𝑝) during fluid resuscitation 











where 𝛼 replaces 𝛼𝑢 in equation (13). Equation (17) is a linear time-invariant version 










This plant transfer function meets all the assumptions (P1-P4) for MRAC control 
methodology [27] which are: 







- P2: An upper bound 𝑛 on the degree 𝑛𝑝 of the transfer function denominator 
polynomial 𝑅𝑝(𝑠). 
- P3: The relative degree 𝑛∗ = 𝑛𝑝 − 𝑚𝑝 of 𝐺𝑝(𝑠) is known. 
- P4: The sign of the high frequency gain (𝐾𝑝 = 𝐾𝑚𝑎𝑝 in this case) is known. 
3.3 Two-Step Control Architecture 
 Inspired by previous work [50], the patient is assumed to have suffered 
hemorrhage which has been stopped and treated. After that, the resuscitation algorithm 
is initiated and it operates in two steps: (i) an initial bolus infusion is administered to 
the patient and Hct and MAP measurements are recorded and used to estimate the 
hemodynamic model parameters in equation (17). (ii) a model-reference adaptive 
controller (MRAC) built on the individualized model regulates the blood pressure of 
the patient while estimating 𝐾𝑚𝑎𝑝(𝑡) online. Although an adaptive control algorithm 
should individualize the hemodynamic model and estimate its parameters on its own, 
safe fluid infusion profiles prevents the algorithm from fulfilling persistent excitation 
(rich input signals) conditions. The proposed two-step architecture is intended to 
overcome such challenges by providing an accurate estimate of the model parameters 
through batch system identification in step (1), for the online parameter estimator to 
initialize from. Moreover, this simulation scenario only involves resuscitation only 
(i.e.: not RBC are lost). This allows for the approximation of Hct measurements by the 













Figure (10) below shows how the two-step architecture of the control algorithm in 
further detail. 
 
Figure 10: Two-step control architecture 
3.3.1 Step (1): Batch System Identification 
 In step (1) described above, the patient receives a bolus infusion while the 
Hematocrit (equivalently 𝑦1(𝑡) = Δ𝑉𝐵(𝑡)/𝑉𝐵0 approximation) and MAP (𝑦2(𝑡)) 
measurements are recorded for 40 min. For each patient, these measurements are used 
to estimate the model parameters using batch system identification techniques. To 
identify the model parameters, equation (17) is first discretized using forward Euler 







Δ𝑀𝐴𝑃(𝑖 + 2) + (𝐾𝑇𝑠 − 2)Δ𝑀𝐴𝑃(𝑖 + 1) + (1 − 𝐾𝑇𝑠)Δ𝑀𝐴𝑃(𝑖)




− 𝐾𝑚𝑎𝑝𝑇𝑠] 𝑢(𝑖) 
(20) 
where (𝑖) is the discrete-time index and (𝑇𝑠) is the sampling time. Optimal model 
parameters are then found by solving the following minimization problem 
 Θ∗ = {𝛼∗, 𝐾∗, 𝑉𝐵0
∗ , 𝐾𝑚𝑎𝑝
∗ } = arg min
Θ
(𝜔1‖𝑦1(𝑖) − ?̂?1(𝑖|Θ)‖2 + 𝜔2‖𝑦2(𝑖) − ?̂?2(𝑖|Θ)‖2) (21) 
where ?̂?1 and ?̂?2 refer to the model predicted fractional blood volume change and MAP 
change. The optimal values {𝛼∗, 𝐾∗, 𝑉𝐵0
∗ , 𝐾𝑚𝑎𝑝
∗ } minimize the weighted sum of norms 
of prediction errors in both 𝑦1 and 𝑦2. Note that, because of the approximation in (19), 
we require to estimate one more parameter in this setting (𝑉𝐵0), which represents the 
blood volume prior to the beginning of infusion. However, if only MAP measurements 
were available, then we solve for the following minimization problem: 
 Θ
∗ = {𝛼∗, 𝐾∗, 𝐾𝑚𝑎𝑝









3.3.2 Step (2): Model Reference Adaptive Control 
 A model-reference adaptive controller is constructed using the estimated model 
parameters {𝛼∗, 𝐾∗, 𝑉𝐵0
∗ , 𝐾𝑚𝑎𝑝
∗ }. MRAC structure decomposes into two components: (i) 
the model reference control law (MRC) obtained by model matching, and (ii) the 
update law. In the design of a model reference control law, the control input is designed 
to have 𝑦2(𝑡) = Δ𝑀𝐴𝑃(𝑡) track a desired reference trajectory described by a first order 













where 𝑦𝑚 is the desired time evolution of 𝑀𝐴𝑃(𝑡), 𝑎𝑚 is the model’s time constant of 
15 minutes and 𝑟 is the reference target value of Δ𝑀𝐴𝑃(𝑡) (i.e.: the desired change in 
MAP from the first measurement). The goal of MRC is to achieve perfect tracking by 
asymptotically driving the output tracking error 𝑒𝑡𝑟(𝑡) = 𝑦2(𝑡) − 𝑦𝑚(𝑡) to zero. The 
reference model in equation (23) also meets the reference model assumptions [27] 
which are: 
- M1: reference model transfer function numerator and denominator 
polynomials are monic Hurwitz polynomials of degree 𝑞𝑚, 𝑝𝑚 respectively 
where 𝑝𝑚 ≤ 𝑛. 
- M2: The relative degree 𝑛𝑚
∗ = 𝑝𝑚 − 𝑞𝑚 of is the same as that for 𝐺𝑝(𝑠). 







𝑦2(𝑡) + 𝜃3𝑦2(𝑡) + 𝜃4𝑟(𝑡) (24) 
 
Figure 11: Model-Reference Control law [27] 












(𝑠 + 𝜆 − 𝜃1)(𝑠2 + 𝐾𝑠) − 𝐾𝑚𝑎𝑝 (𝑠 +
𝐾
1 + 𝛼) (𝜃2 + 𝜃3
(𝑠 + 𝜆))
𝑟(𝑠) (25) 
For perfect model matching, the transfer function in (25) must be equal to the reference 
model transfer function (23). This is known as the certainty equivalence principle and 
is used to find the mapping between plant parameters and controller parameters. 









(𝑠 + 𝜆 − 𝜃1)(𝑠2 + 𝐾𝑠) − 𝐾𝑚𝑎𝑝 (𝑠 +
𝐾
1 + 𝛼) (𝜃2 + 𝜃3
(𝑠 + 𝜆))
 (26) 
Solving equation (26) for the controller parameters 𝜃1, 𝜃2, 𝜃3, 𝜃4 yields: 
 















and the control law (24) becomes: 












+ [𝐾 − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)} (28) 
However, true controller parameters 𝜃s are not known because true {𝛼, 𝐾, 𝐾𝑚𝑎𝑝} are 
unknown. Our best approximation to the control law so far is to replace the parameters 
{𝛼, 𝐾, 𝐾𝑚𝑎𝑝} with their batch system identification estimates {𝛼
∗, 𝐾∗, 𝐾𝑚𝑎𝑝
∗ } from 
either (21) or (22), depending on available measurements. As described in chapter (2), 
𝛼 and 𝐾 are regarded as constant parameters and will be fixed at their batch system 









 . True 𝜃 is replaced by its estimate 𝜃(𝑡) in the control law (28) to 
yield: 






 + 𝜃(𝑡) {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠 + 𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)} (29) 
The update law for 𝜃(𝑡) is derived using Lyapunov theory in the following section 
3.4 Adaptive Law and Stability Analysis 
We investigate the stability of the adaptive law proposed in section (3.3) using the 
following Lyapunov analysis. The output 𝑦2 in figure (10) can be expressed as [30]: 





?̃?(𝑡) {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠 + 𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)} (30) 
where ?̃?(𝑡) = 𝜃(𝑡) − 𝜃 denotes the parameter estimation error. Let the tracking error 






?̃?(𝑡) {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠 + 𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)} (31) 
For notational simplicity, let 
 𝜓(𝑡) = {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠 + 𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)} (32) 
For Lyapunov stability analysis we propose the following Lyapunov function 









The time derivative of (32) is given by: 










 ?̇?𝑡𝑟(𝑡) = −𝑎𝑚𝑒𝑡𝑟(𝑡) + 𝐾𝑚𝑎𝑝?̃?(𝑡)𝜓(𝑡) (35) 
Substituting (35) into equation (34) gives: 
 ?̇? (𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) = −𝑎𝑚𝑒𝑡𝑟




Since the assumption was made earlier that 𝐾𝑚𝑎𝑝(𝑡) is a constant or slowly varying 
parameter, then ?̇̃?(𝑡) = ?̇?(𝑡). To ensure negative definiteness of the time derivative of 
Lyapunov function, we choose the adaptation law of 𝜃(𝑡) as 




+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)} (37) 
Plugging equation (37) back into (36) gives 
 ?̇? (𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) = −𝑎𝑚𝑒𝑡𝑟
2 (𝑡) ≤ 0 (38) 
Since 𝑉(𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) is positive definite and ?̇?(𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) is negative semi-definite, 
then 𝑉(𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) is bounded. Hence, the plant model (18) and the adaptation law 
(37) are globally stable and consequently, 𝑒(𝑡), 𝜓(𝑡) and ?̃?(𝑡) are bounded. Since 𝑒(𝑡) 
and ?̃?(𝑡) are bounded, then ?̇?(𝑡) is bounded as in (35). Moreover, since ?̇?(𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) 
is bounded, then ?̈?(𝑒𝑡𝑟(𝑡), ?̃?(𝑡)) is also bounded and by invoking Barbalat’s lemma we 




𝑒(𝑡) = 0. 
Therefore, stability of the proposed control algorithm is guaranteed. 
To evaluate the controller performance under different measurement availability 
scenarios, we will introduce composite adaptation terms into equation (35). First, we 
will make use of both fractional blood volume measurements 𝑦1 and MAP 
measurements 𝑦2 in the adaptation law as a combination of tracking error 𝑒𝑡𝑟(𝑡) =












∗  (39) 
The composite term in equation (39) is trying to minimize the input prediction error 









∗ . We refer to equation 
(39) as the 2-measurement composite adaptation scheme. 
Similarly, we will consider using MAP measurements only, which is more clinically 
plausible since fractional blood volume measurements are not easy to obtain. When 
only MAP measurements are available, we use an adaptation law that is a combination 
of tracking error 𝑒𝑡𝑟(𝑡) and input-prediction error (𝑢(𝑡) − ?̂?(𝑡)) instead of 𝑦1-
prediction error term. The composite term is derived by re-writing the plant’s input in 
terms of the controller parameters, and then use the gradient rule to minimize the input-





























Define the input-prediction error term as 






















We can now simply augment equation (37) with the composite term (equation 42) to 
get the following single-measurement composite adaptation scheme: 














where 𝜓(𝑡) = {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠+𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)}. 
To summarize, in this chapter we proposed a two-step control architecture to regulate 
MAP to a set-value following a reference model trajectory. In-silico simulation 
scenario assumes that a patient suffers hemorrhage which is then stopped and treated, 
after which a two-step resuscitation control algorithm is initiated. First step involves a 
bolus fluid infusion and measurement collection which are later used to individualize 
the underlying hemodynamic model. Then, a semi-adaptive model reference adaptive 
controller is built using the individualized model to regulate MAP to a set-value. The 
control law is given in equation (29), and is expressed as: 






 + 𝜃(𝑡) {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠 + 𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)}  
with the parameter 𝜃(𝑡) being the online estimate of 1/𝐾𝑚𝑎𝑝. To evaluate the 
performance of the controller and online estimation of 𝜃(𝑡) under different 
measurement availability scenarios, we proposed three versions for 𝜃(𝑡) update laws: 
• Plain MRAC:  






• Single measurement composite adaption scheme:  














• 2-measurement composite adaptation scheme:  







where again, 𝜓(𝑡) = {[𝜆2 − 𝜆𝐾∗]
𝑦2(𝑡)
𝑠+𝜆
+ [𝐾∗ − 𝑎𝑚 − 𝜆]𝑦2(𝑡) + 𝑎𝑚𝑟(𝑡)}. In the next 
chapter, a rigorous in-silico evaluation of the proposed controller, with the 
corresponding three variations of the update law, is conducted using a highly nonlinear, 







Chapter 4:  In-Silico Evaluation of Proposed Controllers 
In this chapter, we will present a rigorous in-silico evaluation of the controllers 
discussed in chapter 3. First, we will explain the simulation resuscitation scenario, then 
we will show how the controllers perform on the same model used for control design 
(for proof of concept). For a more rigorous evaluation, we used a highly nonlinear, well 
established computer model of human cardiovascular physiology developed by Arthur 
Guyton [34] as basis for our in-silico testbed. Using this model, we generated a cohort 
of 100-virtual subjects by perturbing key model parameters within a physiological 
range. Results are analyzed and discussed in further detail in chapter 5. 
4.1 In-silico Testing Scenario 
The testing scenario is as follows: the patient is assumed to have lost blood (or 
fluid) prior to the resuscitation process, then after hemorrhage is treated and stopped, 
an initial bolus infusion is given followed by the closed loop control action (see figure 
(12)). For simulation purposes, the lost blood is assumed to be a total of 2.5L over a 
time period of 120 minutes. Then, 120 minutes after hemorrhage had taken place, we 
begin resuscitation by first infusing a fluid bolus of 0.5L for 30 minutes, then monitor 
the patient’s response for 10 minutes. During these 40 minutes, the patient’s fractional 
blood volume and mean arterial pressure data are collected and used in “step 1: batch 
system identification” (check section 3.3.1 above). Then, 160 minutes after the patient 
had experienced hemorrhage, the MRAC adaptive control law, built using the collected 
data, is initiated to regulate mean arterial blood pressure to some set-point given by the 







Figure 12: In-silico resuscitation scenario 
4.2 Proof of Concept of Proposed Control Law 
It is usually a good rule of thumb to test the controller on the same model used 
for controller design. Results are expected to be identical to what theory dictates in 
chapter 3, and the reason behind showing such results it to ensure that the controller 
works and help understand the controllers’ performance when tested on a more realistic 
(highly nonlinear) model later in this chapter. 
4.2.1 Plain MRAC and Single-Measurement Composite Adaptation Schemes 
As explained in chapter 3, we investigated different versions of the controller’s 
update law: (i) plain MRAC update law, (ii) single-measurement composite adaptation 
scheme and (iii) 2-measurement composite adaptation scheme. In this section we will 
show the results of testing the controller on the same simplified model used for 
controller design for the first two versions, i.e.: using plain MRAC and single-
measurement composite adaptation. For sake of simulation, model parameters were 
chosen within a physiological range as 𝛼 = 1.3478, 𝑉𝐵0 = 4.6043, 𝐾 = 0.0946 and 






use MAP measurements only, and therefore share the same procedure for step (1) batch 
system identification that solves for model parameters using (22). As seen in figure 
(13), the estimated parameters perfectly match the model parameters. 
 
Figure 13: Batch system identification results for plain MRAC and single-measurements case 
At this point the MRAC control law is initiated to regulate MAP to a set point of 30 
mmHg increase along with the adaptive laws (equations 37 and 40 respectively) to 
estimate 𝐾𝑚𝑎𝑝 online. The results of equation (37) shown in figure (14a) clearly show 
the effect of lack of information when using plain MRAC as opposed to using the 
single-measurement composite adaptation scheme in figure (14b) (equation 43). As 
reported in [52], the use of input-prediction error composite term in the adaptation rule 







Figure 14: Tracking and online estimation performance for (a) plain MRAC and (b) single-measurement 
composite adaptation 
4.2.2 Two-Measurements Composite Adaptation Scheme 
Here we follow a similar procedure to the one followed in section 4.2.1, except 
that in the batch system identification step we use both measurements to solve for the 
model parameters 𝑉𝐵0, 𝛼, 𝐾, and 𝐾𝑚𝑎𝑝 as in equation (21). Again, the estimated 
parameters perfectly match the model parameters as seen in figure (15). The tracking 
and estimation performance, as given by equations (29, 39), is shown in figure (16). 
It is clear from figure (16) that availability of both sources of information (namely, Hct 
and MAP) allowed us to achieve perfect tracking of 𝐾𝑚𝑎𝑝(𝑡) online without requiring 








Figure 15: Batch system identification results for two-measurements case 
 
Figure 16: Tracking and online estimation performance in the presence of two measurements 
4.3 Guyton’s Model and Virtual Subjects Generation 
Arthur Guyton in [34] developed a computer simulation model as an analysis 






factors that control arterial pressure. As seen in figure (17) the model is divided into 
eight sub-models: (1) circulatory dynamics, (2) interstitial fluid, (3) autoregulation, (4) 
sympathetic simulation, (5) kidney output, (6) pressure positive feedback, (7) function 
curve adaptation, and (8) angiotensin. Slight extensions were made to this model in 
order to accommodate the application of the proposed closed-loop fluid resuscitation 
control algorithm: (i) Introduce the capability of the model to simulate hemorrhage and 
resuscitation. Such blood volume changes were simulated by adding and subtracting 
fluid to the intravascular compartment directly. (ii) Incorporate plasma volume and red 













The computer model proposed by Arthur Guyton has over 40 constant parameters 
describing the interactions between 8 intermediate subsystems that control the arterial 
pressure. Out of the 40 parameters, some are key “multiplier factors” which generally 
determine the physiology of the simulated patient. For example, Heart Strength (HS) 
represents the heart pumping capacity and is used to calculate cardiac output by 
multiplying it with sympathetic stimulation. Another example is Basic Arterial 
Resistance (RAB) which is used along with other signals to calculate TPR (total 
peripheral resistance) eventually. Table (2) summarizes the key parameters of Guyton’s 
model 
Table 2: Summary of Guyton's model key parameters 
Parameter Physiological Interpretation Parameter Physiological Interpretation 
RAB Baseline arterial resistance SYMKID 
Effects of sympathetic signals on 
kidney function multiplier 
HS Heart strength multiplier ANGVMC Angiotensin multiplier constant 
NN 
Fluid filtration from capillaries 
into tissue space multiplier 
ANGSHC 
Angiotensin renal function curve 
shift constant 
CV Capacitance venous tree VVOB 
Baseline unstressed venous 
volume 
 
By randomly perturbing these key parameters from their nominal values within a 
plausible physiological range, we generated a cohort of 100 virtual subjects, which will 
be used to conduct the in-silico testing. Guyton’s model is based on human physiology 
so it should be noted again that although we verified the proposed cardiovascular model 
using sheep data (section 2.4), the great similarities that exist between human and sheep 






scenarios. Figure (18) shows the samples that were drawn for the 100 virtual patients 
of the 8 key parameters. Also shown in figure (18) is the range of pre-hemorrhage blood 




Figure 18: Model parameters distribution and BV-MAP values for all 100 subjects 
To make the testing scenario as realistic as possible, the algorithm was implemented 
digitally with a sampling time of 0.5 min. Moreover, fractional blood volume and mean 
arterial pressure measurements were contaminated by adding a uniform random noise 
of sizable magnitude (+/- 0.01 and +/- 2 mmHg) respectively. This reflects the 
inaccuracy in blood hematocrit saturation and MAP measurements [53]. To dampen 






smoothed using 6-point moving average digital filter before being used in both steps of 
the control architecture. 
4.4 Simulation Results 
 In this section, we will show simulation results on Guyton’s model for a 
nominal subject (i.e: 5L pre-hemorrhage blood volume and 100mmHg pre-hemorrhage 
mean arterial pressure). 
 
Figure 19:In-silico simulation scenario of a nominal subject 
We can see from figure (19) that BV and MAP of the patient dropped to ~4.25L and 
~82mmHg after hemorrhage (T=240 min). The goal of the control algorithm is to raise 
the blood pressure of the patient by 30mmHg. During step (1) of the control architecture 
which starts at time (T=240 min), a bolus infusion is administered to the patient. This 
raises the blood volume and MAP to ~4.5L and ~88mmHg respectively. The data 
collected between T=240 and T=280 min is used to individualize the hemodynamic 
model using equations (21) or (22) depending on measurement availability. Then, 
MRAC control is initiated and the blood pressure is raised by 30mmHg (82 to 112 
mmHg) following a first order model trajectory with time constant of 15 min. Figures 
(20,21 and 22) show the infusion profile, MAP tracking performance and 𝐾𝑚𝑎𝑝 online 









Figure 20: Tracking performance, infusion profile, and online estimation of 𝐾𝑚𝑎𝑝 – plain MRAC scheme 
 







Figure 22: Tracking performance, infusion profile and online estimation of 𝐾𝑚𝑎𝑝 – two measurement CAC 
 
We can see from the figures above that tracking performance was achieved for all three 
versions of the control algorithm, while online estimation of 𝐾𝑚𝑎𝑝 was only possible 
when both measurements (Hct and MAP) were available (figure 22). However, it 
performed slightly worse in terms of tracking as evident of the more oscillatory 
behavior of the response. This is due to the tracking-estimation tradeoff in adaptive 
control. When more noisy measurements are being fed to the adaptation law to get 
better estimates, worse tracking performance is observed [54].  
From figures (20-21), contrary to what is expected by theory, plain MRAC scheme 
provided better online estimation performance than single-measurement composite 
adaptation scheme. This is due to the inaccurate estimates of 𝛼 and 𝐾 in the batch 
system identification step, which are used in the input prediction error composite term 
in equation (43). Further investigation supports this hypothesis. First, we realize that 






values by exciting the model using a rich signal (white noise) and performing system 
identification. “True” 𝛼 is found by its definition 𝛼 =
Δ𝑉𝐼𝑆𝐹
Δ𝑉𝐵
. Table (3) shows a sample 
result for “true” vs estimated 𝛼, 𝐾. Second, we check our hypothesis by plugging in the 
“true” values in the input prediction error term in equation (43). 
Table 3: True vs estimated K, 𝛼 values for one virtual patient 
 “True” values Batch SYSID results (eqn. 22) 
𝑲 0.0380 0.15 
𝜶 3.1937 5.999 
 
 
Figure 23: Comparison between the performance of single-measurement composite adaptation using "true" and 
estimated 𝛼 and 𝐾 
In figure (23), we can see that using “true” values we get better performance and online 






In this chapter, we investigated the tracking and parameter estimation performance of 
a semi-adaptive controller under different measurement availability scenarios. Details 
of an in-silico test done on a highly nonlinear computer model of human cardiovascular 
system were shown. Results of the in-silico test on a nominal subject showed that our 
proposed control algorithm successfully tracked a first order reference model trajectory 
change in MAP. Moreover, depending on the quality and availability of measurements, 
we were able to estimate the time-varying parameter describing the relationship 
between BV and MAP. In the next chapter, we will provide a more detailed analysis of 
the results obtained from the in-silico testing over a cohort of 100 virtual patients and 








Chapter 5:  Results, Discussion and Conclusions 
 In chapter 4, we presented the in-silico testing scenario and provided the results 
on a nominal patient for the control architecture under different measurement 
availability scenarios. Here, we will discuss a more rigorous test of the controller by 
running similar simulations on a cohort of a 100 virtually generated patients as 
discussed in section (4.3). Obviously, it is not feasible to show the results for all 100 
subjects, therefore, in this chapter we wish to quantify the tracking and estimation 
performance of the different versions of the adaptive controller. To do so, we analyze 
the results by conducting a statistical t-test and discuss the key features of the proposed 
controllers. 
5.1 Performance Error Metrics 
To quantify both tracking and estimation performance, we ought to use a 
common metric to evaluate the performance of computer-controlled infusion pumps, 
better known as Performance Error (PE) metrics [55]. In quantifying tracking 
performance of a controller, performance error is defined as the ratio of the discrepancy 




⋅ 100% (44) 
For quantifying online 𝐾𝑚𝑎𝑝(𝑡) estimation, performance error metric is defined as the 










⋅ 100% (45) 
Equations (44, 45) are used to define the following four measures, for the case of 
tracking and estimation independently: (i) Median Absolute Performance Error 
(MDAPE) which is a measure of inaccuracy. 
 𝑀𝐷𝐴𝑃𝐸 = median {|𝑃𝐸|} (46) 
 (ii) Median Performance Error (MDPE): a measure of “bias”. This a signed value and 
represents how much the output (or parameter) overshot or undershot its true values. 
 𝑀𝐷𝑃𝐸 = median {𝑃𝐸} (47) 
 (iii) Divergence: the slope obtained from linear regression of the absolute PE against 
time. This measure describes the time-related trend of the actual versus estimated 
values. 
 Divergence =  
(∑ |𝑃𝐸𝑖| ⋅ 𝑡𝑖
𝑁












 (iv) Wobble: a measure of inter-subject variability as well as an indicator of time-
related changes in tracking or estimation performance. 
 Wobble = median {|𝑃𝐸 − 𝑀𝐷𝑃𝐸|} (49) 
5.2 Tracking Performance Results 
In this section, we will compare the tracking performance of all three versions of the 
proposed controller. We begin by using equation (44) to calculate the PE, then evaluate 
the four metrics explained in section 5.1. In particular, for every patient of the 100 
virtual patients, we run the in-silico simulation and collect the output data (𝑦2) as well 






Finally, the results of each controller for all subjects are reported in Table (5) which 
shows the mean and standard deviation of all the results. 
Table 4: Summary of performance error metrics for tracking performance 







MDAPE [%] 2.886 +/- (1.007) 2.546 +/- (0.72) 2.507 +/- (0.829) 
MDPE [%] 1.741+/- (1.399) -0.698 +/- (1.695) -1.474 +/- (1.201) 
Divergence [%/min] -0.082+/- (0.042) -0.096 +/- (0.063) -0.096 +/- (0.066) 
Wobble [%] 2.043+/- (0.368) 2.498 +/- (0.829) 2.417 +/- (0.836) 
 
The results suggest that the tracking accuracy (MDAPE) of the three controllers, 
although comparable, was significantly different depending on measurement 
availability. Generally, the controller was able to track a first order model change to a 
desired set point successfully. However, when more information is fed to the controller, 
tracking performance slightly deteriorates in exchange of enhanced estimation. MDPE 
results suggest that 2-measurement adaptation scheme overshot (on average) the 
predetermined set point, while single-measurement schemes undershot it. Divergence 
was not significantly different between the three controllers, indicating that there were 
no abnormal time trends and that all controllers successfully tracked the first order 
model trajectory. Finally, results also show how 2-measurement adaptation scheme was 
significantly better in adapting to inter-subject variability as measured by the Wobble 
metric. To make such a conclusion, the following t-test provide a better insight. Using 
MATLAB’s (Mathworks, Natick, MA) one-way analysis of variance tools “ANOVA1” 






metrics (MDAPE, MDPE, Divergence and Wobble). Figures (24-27) show the results 
of this analysis. 
 
Figure 24: Statistical t-test results for tracking performance MDAPE metric 
 







Figure 26: Statistical t-test results for tracking performance Divergence metric 
 
Figure 27: Statistical t-test results for tracking performance Wobble metric 
5.3 Estimation Performance Results 
 In this section, we quantify the online estimation performance of the three 
adaptation schemes. The same performance error metrics are followed, that is: we use 






for each patient. Following the same procedure in 5.2, the table below lists the mean 
and standard deviation of the PE metrics for all three adaptation schemes. 
Table 5: Summary of performance error metrics for estimation performance 







MDAPE [%] 0.051 +/- (0.032) 0.517 +/- (0.052) 0.331 +/- (0.119) 
MDPE [%] 0.031 +/- (0.051) -0.517 +/- (0.052) -0.326 +/- (0.132) 
Divergence [%/min] 0.000 +/- (0.000) 0.001 +/- (0.001) -0.001 +/- (0.001) 
Wobble [%] 0.009 +/- (0.001) 0.021 +/- (0.007) 0.015 +/- (0.006) 
 
The results suggest that availability of two measurements is best for online estimation, 
which is expected because we have more information about the system. However, as 
opposed to what is expected by the theory presented in chapter 3, the plain MRAC 
provides better estimates for online estimation of 𝐾𝑚𝑎𝑝(𝑡) rather than the single-
measurement composite adaptation scheme. This is due to the presence of inaccurate 
𝛼, 𝐾 in the input prediction error composite term that caused deteriorated estimate of 
𝜃(𝑡) and hence 𝐾𝑚𝑎𝑝(𝑡) (see discussion in section 4.4). Also, we can see from table 
(5) that divergence metric for 2-measurement composite adaptation scheme was 0, 
which indicates that we managed to maintain perfect online parameter estimation for 
all subjects as indicated by the wobble metric as well (the estimation algorithm also 
adapted to inter0subject variability). To further analysis this hypothesis, we conducted 








Figure 28: Statistical t-test results for estimation performance MDAPE metric 
 







Figure 30: Statistical t-test results for estimation performance Divergence metric 
 
Figure 31: Statistical t-test results for estimation performance Wobble metric 
5.4 Conclusions and Discussion 
In this work, we proposed an extension to an existing hemodynamic model of 
blood volume response to fluid infusion to include mean arterial pressure response to 






versions of a two-step semi-adaptive closed loop control algorithm for the development 
of an autonomous fluid resuscitation system and investigated them under different 
measurement availability scenarios. To evaluate the performance of the control 
algorithms, we conducted an in-silico test on a highly non-linear, well-established 
computer model of cardiovascular system (Guyton’s model) on a cohort of 100 
virtually generated patients. The virtual patients were generated by randomly 
perturbing eight key parameters of the model within a physiological range. The results 
were presented in chapter 4, and the following two points were observed: 
1) The use of two-measurements adaptation scheme provides slightly worse (more 
oscillatory) tracking performance to reference model trajectories, than when 
using single-measurement adaptation schemes. 
2) The use of two-measurements adaptation scheme provides better (perfect) 
online estimation of model parameter 𝐾𝑚𝑎𝑝(𝑡), than when using single-
measurement adaptation schemes. 
These two points indicate that a trade-off between tracking and estimation performance 
exists in adaptive control algorithms. This is due to the adaptation-noise rejection 
tradeoff in the adaptation algorithm and the fact that the two-measurement adaptation 
scheme is exposed to more error sources than its counterparts. 
Statistical test done on results of an in-silico test of the control algorithm for 100 virtual 
patients, supports the existence of such trade-off between tracking and estimation 
performance. The deterioration in tracking performance, although small in terms of 
performance error (average increase of ~0.3%), was significant when compared to the 






5.5 Future Work 
 The extension of the hemodynamic model to include mean arterial pressure 
response to blood volume perturbations was described using a time-varying parameter 
𝐾𝑚𝑎𝑝(𝑡), which is intended to capture the sensitivity of SV and 𝐸𝑎 changes to BV 
changes. One important assumption in the development of this control algorithm was 
the assumption that 𝐾𝑚𝑎𝑝(𝑡) is generally positive during fluid resuscitation. However, 
this assumption is not true for subjects that are not responsive to fluid resuscitation. 
This is one limitation of the case of single-measurement adaptation scheme, which will 
be addressed in future work. Second, physiological interpretability was not strictly 
made since 𝐾𝑚𝑎𝑝(𝑡) describes the responsiveness of the patient to fluid infusion and it 
does not have an exact counterpart in physiology literature. However, it is 
physiologically plausible: for example, high 𝐾𝑚𝑎𝑝(𝑡) values indicate high 
responsiveness of MAP during fluid infusion. 
Online estimation of 𝐾𝑚𝑎𝑝(𝑡) is useful for learning more about the responsiveness of 
the patient to fluid infusion. This can be incorporated in the design of an autonomous 
set point selection controller where the need for the clinician to enter a specified set 
point is not required, but rather a set of upper and lower bounds that should not be 
exceeded. To get almost perfect estimates of 𝐾𝑚𝑎𝑝(𝑡), we require the availability of 
both MAP measurements and Hct measurement, which highly affects the estimates of 
𝑉𝐵0
∗  in equation (39). Hct measurements are hard to obtain in clinical scenarios but 







Finally, this controller can potentially be used in a Hardware-in-the-Loop (HIL) test to 
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